506 related articles for article (PubMed ID: 22227985)
1. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
Mascitti KB; Edelstein PH; Fishman NO; Morales KH; Baltus AJ; Lautenbach E
Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985
[TBL] [Abstract][Full Text] [Related]
2. Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.
Canty E; Carnahan B; Curley T; Anususinha E; Hamdy RF; Ericson JE
Pediatr Infect Dis J; 2021 May; 40(5):429-433. PubMed ID: 33196562
[TBL] [Abstract][Full Text] [Related]
3. Reduced Vancomycin Susceptibility of Methicillin-Susceptible Staphylococcus aureus Has No Significant Impact on Mortality but Results in an Increase in Complicated Infection.
Sullivan SB; Austin ED; Stump S; Mathema B; Whittier S; Lowy FD; Uhlemann AC
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28507105
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin MICs and risk of complicated bacteremia by glycopeptide-susceptible Staphylococcus aureus.
Falcón R; Mateo E; Oltra R; Giménez E; Albert E; Torres I; Navarro D
Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):903-912. PubMed ID: 30729396
[TBL] [Abstract][Full Text] [Related]
5. Effect of reduced vancomycin susceptibility on clinical and economic outcomes in Staphylococcus aureus bacteremia.
Han JH; Mascitti KB; Edelstein PH; Bilker WB; Lautenbach E
Antimicrob Agents Chemother; 2012 Oct; 56(10):5164-70. PubMed ID: 22825122
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin.
McMullen AR; Lainhart W; Wallace MA; Shupe A; Burnham CD
Eur J Clin Microbiol Infect Dis; 2019 Dec; 38(12):2323-2330. PubMed ID: 31446513
[TBL] [Abstract][Full Text] [Related]
7. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
[TBL] [Abstract][Full Text] [Related]
8. The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.
Honda H; Doern CD; Michael-Dunne W; Warren DK
BMC Infect Dis; 2011 Dec; 11():335. PubMed ID: 22142287
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
[TBL] [Abstract][Full Text] [Related]
10. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
[TBL] [Abstract][Full Text] [Related]
11. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
[TBL] [Abstract][Full Text] [Related]
12. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia.
Yeh YC; Yeh KM; Lin TY; Chiu SK; Yang YS; Wang YC; Lin JC
J Microbiol Immunol Infect; 2012 Jun; 45(3):214-20. PubMed ID: 22571999
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.
Horne KC; Howden BP; Grabsch EA; Graham M; Ward PB; Xie S; Mayall BC; Johnson PD; Grayson ML
Antimicrob Agents Chemother; 2009 Aug; 53(8):3447-52. PubMed ID: 19506056
[TBL] [Abstract][Full Text] [Related]
14. Reduced vancomycin susceptibility and staphylococcal cassette chromosome mec (SCCmec) type distribution in methicillin-resistant Staphylococcus aureus bacteraemia.
Han JH; Edelstein PH; Lautenbach E
J Antimicrob Chemother; 2012 Oct; 67(10):2346-9. PubMed ID: 22761330
[TBL] [Abstract][Full Text] [Related]
15. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
Panesso D; Planet PJ; Diaz L; Hugonnet JE; Tran TT; Narechania A; Munita JM; Rincon S; Carvajal LP; Reyes J; Londoño A; Smith H; Sebra R; Deikus G; Weinstock GM; Murray BE; Rossi F; Arthur M; Arias CA
Emerg Infect Dis; 2015 Oct; 21(10):1844-8. PubMed ID: 26402569
[TBL] [Abstract][Full Text] [Related]
16. Methicillin-resistant Staphylococcus aureus bacteremia in hemodialysis and nondialysis patients.
Kan LP; Lin JC; Chiu SK; Yeh YC; Lin TY; Yang YS; Wang YC; Wang NC; Yeh KM; Chang FY
J Microbiol Immunol Infect; 2014 Feb; 47(1):15-22. PubMed ID: 23040238
[TBL] [Abstract][Full Text] [Related]
17. More accurate measurement of vancomycin minimum inhibitory concentration indicates poor outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.
Shoji H; Maeda M; Shirakura T; Takuma T; Ugajin K; Fukuchi K; Ishino K; Niki Y
Int J Antimicrob Agents; 2015 Nov; 46(5):532-7. PubMed ID: 26364848
[TBL] [Abstract][Full Text] [Related]
18. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of vancomycin minimum inhibitory concentration of 2 μg/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia.
Takesue Y; Nakajima K; Takahashi Y; Ichiki K; Ishihara M; Wada Y; Tsuchida T; Uchino M; Ikeuchi H
J Infect Chemother; 2011 Feb; 17(1):52-7. PubMed ID: 20625789
[TBL] [Abstract][Full Text] [Related]
20. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
